Tune in for Motley Fool Advisor Karl Thiel’s debut on Industry Focus as our resident biotech expert discusses the advances and challenges of CRISPR gene-editing technology, as well as how investors should be thinking about the space.

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]